"This analysis explores the critical shifts in the sector, highlighting a projected growth trajectory driven by technological integration and changing consumer dynamics."

According to analysts at Vantage Market Research, the United States Pathology Laboratories Market size is worth USD 107.6 Billion in 2025 and is projected to reach USD 229.75 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 7.5% from 2026 to 2035. Key trends include rapid adoption of digital pathology platforms, AI-assisted diagnostics, molecular pathology expansion, enterprise laboratory automation, precision medicine integration, centralized laboratory networks, and increasing investments in advanced oncology diagnostics.

United States Pathology Laboratories Market Overview

The United States Pathology Laboratories Market continues to play a vital role in the country’s healthcare ecosystem by delivering highly accurate diagnostic information that supports disease detection, treatment planning, precision medicine, and long-term patient management. Pathology laboratories have evolved from conventional tissue examination facilities into advanced diagnostic centers integrating molecular diagnostics, digital pathology, artificial intelligence, and laboratory automation to improve clinical outcomes and operational efficiency.

Growing demand for personalized medicine, increasing cancer screening programs, and rising prevalence of chronic and infectious diseases are accelerating investments in modern laboratory infrastructure. Healthcare providers are expanding diagnostic capabilities by implementing digital slide imaging, automated specimen processing, laboratory information systems, and AI-assisted image analysis that enable faster turnaround times while improving diagnostic consistency and workflow productivity.

The market is also benefiting from healthcare consolidation, where integrated delivery networks are centralizing pathology operations to improve resource utilization, standardize diagnostic quality, and strengthen procurement efficiency. Enterprise buyers increasingly prioritize laboratories offering comprehensive testing portfolios, seamless electronic health record integration, regulatory compliance, cybersecurity, and scalable automation capabilities.

In addition, continuous advancements in molecular pathology, genomic sequencing, biomarker analysis, and computational pathology are expanding the role of pathology laboratories in oncology, rare disease diagnostics, infectious disease surveillance, and companion diagnostics. As healthcare organizations continue modernizing laboratory operations to support precision healthcare initiatives, the US Pathology Laboratories Market is expected to witness sustained long-term growth driven by technological innovation and enterprise digital transformation.

ARUP Laboratories Strengthened Enterprise Interoperability Through Advanced Laboratory Information Systems

February 2026 — ARUP Laboratories deployed enhanced laboratory information system capabilities designed to strengthen interoperability with enterprise healthcare platforms, improving diagnostic workflow integration, reporting efficiency, and clinical data accessibility across healthcare organizations.

Key Takeaways from the Report

Growing adoption of precision medicine and personalized healthcare is significantly increasing demand for advanced pathology laboratory services across the United States.
Digital pathology platforms and AI-assisted diagnostics are transforming laboratory workflows by improving diagnostic accuracy, operational efficiency, and remote collaboration capabilities.
Rising cancer screening volumes and molecular diagnostic testing continue driving investments in advanced pathology technologies and laboratory modernization.
Healthcare system consolidation is encouraging centralized laboratory networks that improve procurement efficiency, standardized quality management, and enterprise-scale diagnostic operations.
Automated specimen processing, laboratory information systems, and digital workflow management are strengthening productivity while reducing turnaround times.
Molecular pathology, genomic profiling, and biomarker testing are expanding rapidly as clinicians increasingly rely on targeted therapies and precision oncology programs.
Cybersecurity, regulatory compliance, interoperability, and integrated electronic health record connectivity remain critical priorities influencing enterprise laboratory procurement decisions.

Top Players

Quest Diagnostics
Labcorp
Sonic Healthcare USA
Mayo Clinic Laboratories
ARUP Laboratories
NeoGenomics Laboratories
BioReference Health
Cleveland Clinic Laboratories
PathGroup
Inform Diagnostics
Aurora Diagnostics
CBLPath
Miraca Life Sciences
American Esoteric Laboratories

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all major aspects of the market, including growth drivers, restraints, opportunities, challenges, competitive dynamics, and emerging technology trends. The analysis includes detailed evaluations of digital pathology, molecular diagnostics, laboratory automation, artificial intelligence integration, workflow modernization, regulatory frameworks, and procurement intelligence. In addition, our reports provide comprehensive regional analysis, technology roadmaps, PESTLE analysis, competitive benchmarking, company profiles, and strategic recommendations, enabling healthcare organizations, investors, and industry participants to make informed business decisions.

Latest Announcement

March 2025 — Labcorp expanded its precision oncology testing portfolio by introducing additional molecular diagnostic capabilities designed to support personalized treatment selection, biomarker analysis, and advanced cancer care across healthcare networks.